Charleston area pain sufferers can now sign up for clinical tria - WCIV-TV | ABC News 4 - Charleston News, Sports, Weather

Charleston area pain sufferers can now sign up for clinical trials

Posted: Updated:

CHARLESTON, S.C. (WCIV) – The Pain Specialists of Charleston is hosting a clinical trial for sufferers of chronic lower limb pain in two Lowcountry locations.

According to publicists for the ACCURATE study, trials will be held in Charleston and Mount Pleasant.

The studies will focus on a device that delivers electrical stimulation to the Dorsal Root Ganglion (DRG), which is the branch of the spinal cord that serves as the pain traffic signal.

Physicians are looking for 152 patients with chronic lower limb pain caused by Complex Regional Pain Syndrome (CRPS) or post-surgical nerve damage.

According to the website, to qualify you must fall in the following categories:

· Patients must be between the ages of 22-75.

· Have a history of chronic lower limb pain for greater than six months

· Not have had a previous spinal cord stimulator device and have failed previous therapies to reduce their pain

Proponents of the study say chronic post-surgical pain , which affects up to 35 percent of patients who undergo hernia surgery and 50 to 85 percent of patients who undergo amputations.

ACCURATE study researchers hope stimulation of the DRG may help stop the pain signals from traveling to the brain and provide long-term relief for patients who suffer from chronic lower back pain.

If you meet any of the criteria, or feel you could benefit from the trial, go to www.accuratestudy.com or call (888)-978-8397.



Powered by WorldNow

ABCNews4 WCIV-TV

888 Allbritton Dr.
Mt. Pleasant, SC 29464
843-881-4444 | Advertising Information

Public Information File

For assistance with accessing WCIV-TV's public information file, click here.

Advertising

Advertising Credit Application and Terms and Conditions PDF.

Powered by WorldNow
All content Copyright © 2014 WCIV and Worldnow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.